» Articles » PMID: 9330681

Antisense-mediated Inhibition of Aminopeptidase N (CD13) Markedly Decreases Growth Rates of Hematopoietic Tumour Cells

Overview
Date 1997 Jan 1
PMID 9330681
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Advancement of fluorescent aminopeptidase probes for rapid cancer detection-current uses and neurosurgical applications.

Shimizu T, Tanaka S, Kitagawa Y, Sakaguchi Y, Kamiya M, Takayanagi S Front Surg. 2024; 11:1298709.

PMID: 38516394 PMC: 10954885. DOI: 10.3389/fsurg.2024.1298709.


Proteomic analysis of urine exosomes reveals renal tubule response to leptospiral colonization in experimentally infected rats.

RamachandraRao S, Matthias M, Kokoy-Mondragon C, Mondrogon C, Aghania E, Park C PLoS Negl Trop Dis. 2015; 9(3):e0003640.

PMID: 25793258 PMC: 4368819. DOI: 10.1371/journal.pntd.0003640.


The moonlighting enzyme CD13: old and new functions to target.

Mina-Osorio P Trends Mol Med. 2008; 14(8):361-71.

PMID: 18603472 PMC: 7106361. DOI: 10.1016/j.molmed.2008.06.003.


Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.

Terauchi M, Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S BMC Cancer. 2007; 7:140.

PMID: 17655775 PMC: 2000898. DOI: 10.1186/1471-2407-7-140.


Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Bauvois B, Dauzonne D Med Res Rev. 2005; 26(1):88-130.

PMID: 16216010 PMC: 7168514. DOI: 10.1002/med.20044.